# Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 Years

> **NCT05156528** · PHASE3 · UNKNOWN · sponsor: **Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd** · enrollment: 21000 (estimated)

## Conditions studied

- Dysentery
- Shigellosis

## Interventions

- **BIOLOGICAL:** S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT05156528
- **Lead sponsor:** Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-11
- **Primary completion:** 2024-01-11
- **Final completion:** 2024-01-11
- **Target enrollment:** 21000 (ESTIMATED)
- **Last updated:** 2022-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05156528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05156528, "Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 Years". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05156528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*